 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
||||||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
|||||||||||
 |
|
||||||||||||||
|
|
 |
|
 |
|
 |
|
Prevention and Control Program
The ultimate goal of the Prevention and Control Program is to reduce cancer incidence, morbidity, and mortality through behavioral and clinical research to modify cancer risk behaviors and improve quality of life in patients and families. Investigating differences across ethnic groups in cancer risk, responsiveness to behavioral interventions, and quality of life following a cancer diagnosis is an integral component of our program’s research efforts.
Specific Program goals are to:
- Develop, implement, and evaluate interventions to reduce cancer risk factors, including tobacco control and UV/sun exposure, and increasing healthy diet, physical activity, and screening behaviors
- Develop, implement, and evaluate interventions to improve well-being in cancer patients, including increasing access to the latest cancer treatments and enhancing symptom control and quality of life
- Focus research on reducing cancer-related health disparities, particularly through developing interventions that build on cultural values and practices and exploring the effectiveness of interventions in different ethnic groups
Through its Clinical Trials Unit, the Prevention and Control Program enrolls subjects in over one hundred active, National Cancer Institute (NCI) sponsored, and industry sponsored multi-center studies. NCI support for national clinical trials is predominantly through a Minority-Based, Community Clinical Oncology Program (CCOP) award. The Prevention and Control Program includes the NCI supported Cancer Information Service (CIS) of Hawaii which partners with community agencies to provide cancer information and community education throughout the islands and the Pacific.